Journal Information
Vol. 96. Issue 3.
Pages 258-259 (01 March 2022)
Vol. 96. Issue 3.
Pages 258-259 (01 March 2022)
Scientific Letter
Open Access
Use of intravenous prostaglandins in neonatal vasospasm
Utilidad de las prostaglandinas endovenosas en el espasmo vascular neonatal
Cristina Juberías Alzuetaa,
Corresponding author

Corresponding author.
, Cristina Durán Fernández-Feijóob, Jorge Vidal Reyb, Noelia Puime Figueroab, Ana Concheiro-Guisánb
a Hospital Universitario Lucus Augusti, Lugo, Spain
b Hospital Universitario Álvaro Cunqueiro, Vigo, Spain
Article information
Full Text
Download PDF
Full Text
Dear Editor:

Arterial puncture and venepuncture are common procedures in neonatal units, but they are not free of risk.1,2 The most frequent adverse events are infection, vasospasm and vascular thrombosis, in addition to extravasation. We present 2 cases of extremity ischaemia secondary to vascular catheterization in extremely preterm infants and the favourable outcomes achieved with intravenous infusion of prostaglandins.

The first case corresponded to a female infant born at 24+5 weeks of gestation with a birthweight of 640 g. At 32 days post birth, following venepuncture for insertion of a vascular access line in the right forearm, the patient developed pallor and coldness in that forearm in absence of a palpable pulse at the site. The initial management consisted in the application of warm gauze in the contralateral arm and topical administration of nitroglycerine 2% ointment. A Doppler ultrasound scan of the affected limb evinced absence of distal blood flow. Since previous measures had proven ineffective, we decided to initiate treatment with continuous infusion of prostaglandin E2 at a dose of 0.014 µg/kg/min and subcutaneous enoxaparin at a dose of 1.5 mg/kg/12 h. In a few hours, there was evidence of improved perfusion with recovery of normal skin colour, temperature and the humeral, brachial and radial pulses and normalization of the Doppler waveform of the palmar arch. The dose of prostaglandin was tapered off to its complete discontinuation at 48 h of treatment. Enoxaparin was discontinued after 11 days. The patient did not experience complications of either treatment.

The second case corresponded to a male infant born at 26+3 weeks of gestation with a birthweight of 554 g. The mother had a history of deep vein thrombosis with negative results of thrombophilia testing. At 60 days post birth, during an ultrasound-guided catheterization attempt, the right lower extremity appeared pale for a few seconds, with subsequent reperfusion, but followed by posterior swelling of the extremity and an asymmetric femoral pulse relative to the contralateral leg. The extremity was maintained in the extended position and local heat applied to the contralateral extremity, without improvement. A Doppler ultrasound scan evinced blood flow in the common femoral artery, but not in the popliteal and superficial femoral arteries. Continuous infusion of prostaglandin E2 was initiated at a dose of 0.005 mcg/kg/min combined with subcutaneous administration of low-molecular-weight heparin at a dose of 1 mg/kg/12 h. The patient exhibited a favourable clinical and sonographic response that allowed discontinuation of prostaglandin infusion after 3 days of treatment and of heparin after 7 days, and did not experience any adverse events.

Vascular catheterization is performed daily in neonatal care units. Neonates are particularly vulnerable to some of the risks associated with these procedures, such as vasospasm and/or thrombosis, due to the small calibre of their vessels and the immaturity of the coagulation system with a tendency toward hypercoagulation,1,3 risks that are particularly increased in infants with lower gestational ages or lower weights. Vasospasm usually develops within hours, or even minutes, of vascular puncture, while thrombosis tends to develop after a few days or weeks.3 Both can cause ischaemia of varying severity in the involved extremity, with manifestations ranging from pallor to gangrene associated with the absence of pulses distal to the lesion. The diagnosis can be confirmed by angiography, which is the gold standard but an invasive procedure, or bedside Doppler ultrasound, a procedure that is not invasive but requires previous training.1,3 The initial approach should be to maintain the affected extremity in a horizontal position and warm the contralateral limb to produce a reflex vasodilation effect.1–3 If a catheter has been inserted, it should be removed.1,3 Previous studies have described the use of nitroglycerine 0.4% administered topically every 8 h until the resolution of vasoespasm.2 The adverse events associated with this treatment are headache, dizziness, hypotension and methaemoglobinaemia. If there is no improvement, and after careful consideration of potential benefits and risks, especially in preterm infants, treatment can continue with intravenous infusion of prostaglandins, which have proven effective for treatment of vasospasm in adult patients.4,5 We extrapolated the dose used in adults (80 µg/day) since there are no data on the use of prostaglandins for treatment of vasospasm in newborn infants. We estimated that neonates would require approximately 1/10 of the dose used in adults (10 µg/day). In the first patient, we used a higher initial dose of 20 µg/day, which we deemed safe based on evidence on the use of prostaglandins to maintain the patency of the ductus arteriosus in patients with cyanotic heart disease, due to concern that a lower dose may not be effective, which was not the case in the second patient. We believe that our experience may be relevant, given the positive outcomes and lack of complications associated with the treatment. In the case of risk of thrombosis secondary to vasospasm and endothelial damage, prophylaxis with low-molecular-weight heparin is recommended for as long as normal blood flow is not restored.6 Surgical repair is the treatment of last resort.6

M.C. Hermansen, G.M. Hermansen.
Intravascular catheter complications in the neonatal intensive care unit.
Clin Perinatol., 32 (2005), pp. 141-156
R. Mosalli, M. Elbaz, B. Paes.
Topical nitroglycerine for neonatal arterial associated peripheral ischemia following cannulation: a case report and comprehensive literature review.
Case Rep Pediatr., 2013 (2013), pp. 1-7
J. Wu, D. Mu.
Vascular catheter-related complications in newborns.
J Paediatr Child Health., 48 (2012), pp. E91-E95
M. Björck, J.J. Earnshaw, S. Acosta, F. Bastos Gonçalves, F. Cochennec, E.S. Debus, et al.
Editor’s Choice – European Society for Vascular Surgery (ESVS) 2020 Clinical Practice Guidelines on the Management of Acute Limb Ischaemia.
Eur J Vasc Endovasc Surg., 59 (2020), pp. 173-218
J. Li, B. Wang, Y. Wang, F. Wu, P. Li, Y. Li, et al.
Therapeutic effect of liposomal prostaglandin E1 in acute lower limb ischemia as an adjuvant to hybrid procedures.
Exp Ther Med., 5 (2013), pp. 1760-1764
U. Sadat, P.D. Hayes, K. Varty.
Acute limb ischemia in pediatric population secondary to peripheral vascular cannulation: literature review and recommendations.
Vasc Endovascular Surg., 49 (2015), pp. 142-147

Please cite this article as: Juberías Alzueta C, Fernández-Feijóo CD, Vidal Rey J, Puime Figueroa N, Concheiro-Guisán A. Utilidad de las prostaglandinas endovenosas en el espasmo vascular neonatal. An Pediatr (Barc). 2022;96:258–259.

Anales de Pediatría (English Edition)

Subscribe to our newsletter

Article options
es en

¿Es usted profesional sanitario apto para prescribir o dispensar medicamentos?

Are you a health professional able to prescribe or dispense drugs?